Gold and nano-gold in medicine: Overview, toxicology and perspectives

Journal of Applied Biomedicine

Volumn 7, Issue 2, 2009, Pages 75-91

  Panyala, Nagender Reddy ^a   Peña Méndez, Eladia María ^b   Havel, Josef ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Biomolecules; Gold nanoparticles; Gold quantum dots; Nanomedicine; Toxicity

Indexed keywords

ARTEMISININ; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; GOLD; GOLD DERIVATIVE; GOLD NANOPARTICLE; NANOCARRIER; QUANTUM DOT; SODIUM AUROTHIOSULFATE;

BURNING SENSATION; CANCER THERAPY; CONJUGATION; CONTACT ALLERGY; CONTACT DERMATITIS; CYTOTOXICITY; DECREASED APPETITE; DIAGNOSTIC TEST; DNA DETERMINATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG WITHDRAWAL; ECZEMA; EYE SWELLING; FACE EDEMA; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; GENE CONTROL; GENE TARGETING; GOLD THERAPY; HEMATURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; JUVENILE RHEUMATOID ARTHRITIS; LICHENOID ERUPTION; LOW DRUG DOSE; MOUTH DISEASE; MOUTH ITCHING; MOUTH ULCER; NANOIMAGING; NANOMEDICINE; NANOTOXICOLOGY; NEUROIMAGING; NONHUMAN; PROTEINURIA; PRURITUS; RASH; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN DISEASE; SKIN IRRITATION; STOMATITIS; TASTE DISORDER; THROMBOCYTOPENIA; TOXICITY TESTING; WEIGHT REDUCTION;

EID: 67650675151     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2009.008     Document Type: Review

References (99)

1. Bernhard GC: Auranofin therapy in rheumatoid arthritis. J Lab Clin Med 100:167-177, 1982.
2. Bhattacharya R, Patra CR, Earl A, Wang S, Katarya A, Beng LL, Kizhakkedathu JN, Yaszemski MJ, Greipp PR, Mukhopadhyay D, Mukherjee P: Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomed Nanotechnol Biol Med 3:224-238, 2007.
3. Bhattacharya R, Mukherjee P: Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev 60:1289-1306, 2008.
4. Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, Ramming KP, Morton DL: Cryosurgical ablation and radiofrequency ablation for unrespectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 135:657-662, 2000.
5. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ: Radiofrequency ablation in 447 complex unrespectable liver tumours: lessons learned. Ann Surg Oncol 10:52-58, 2003.
6. Brigger I, Dubernet C, Couvreur P: Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631-651, 2002.
7. Bruchez MJ, Maronne M, Gin P, Weiss S, Alivasatos AP: Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013-2016, 1998.
8. Cai W, Gao T, Hong H, Sun J: Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 1:17-32, 2008.
9. Chaffman M, Brogden RN, Heel RC, Speight TM, Avery GS: Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Drugs 27:378-424, 1984.
10. Chan WCW, Nie S: Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281:2016-2018, 1998.
11. Chan WCW, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S: Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13:40-46, 2002.
12. Chang E, Millar JS, Sun J, Yu WW, Colvin VL, Drezek R, West JL: Protease-activated quantum dot probes. Biochem Biophys Res Commun 334:1317-1321, 2005.
13. Chen J, Wang D, Xi J, Au L, Siekkinen A, Warsen A, Li Zhi-Yuan, Zhang H, Xia Y, Li X: Immuno gold nanocages with tailored optical properties for targeted photo thermal destruction of cancer cells. Nano Lett 7:1318-1322, 2007.
14. Chen YS, Hung YC, Liau I, Huang GS: Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett, 2009, in press.
15. Chithrani BD, Ghazani AA, Chan WCW: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668, 2006.
16. Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, Kim SH, Kim HO, Limc YT, Chung BH, Jeong J: Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16-24, 2009.
17. Choi Y, Mecke A, Orr BG, Holl MMB, Baker JR Jr.: DNA-directed synthesis of generation 7 and 5 PAMAM dendrimer nanoclusters. Nano Lett 4:391-397, 2004.
18. Choi Y, Thomas T, Kotlyar A, Islam MT, Baker JR: Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol 12:35-43, 2005.
19. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD: GNPs are taken up by human cells but do not cause acute cytotoxicity. Small 1:325-327, 2005.
20. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR: Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107:459-466, 2006.
21. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P et al.: Early and late complications after radiofrequency ablation of malignant liver tumours in 608 patients. Ann Surg 239:450-458, 2004.
22. Daniel MC, Astruc D: GNPs: assembly, supramolecular chemistry, quantum-size related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104:293-346, 2004.
23. Davis P: Gold therapy in the treatment of rheumatoid arthritis. Can Fam Physician 34:445-452, 1988.
24. Ding Y, Liu J, Wang H, Shen G, Yu R: A piezoelectric immunosensor for the detection of α-fetoprotein using an interface of gold/ hydroxyapatite hybrid nanomaterial. Biomaterials 28:2147-2154, 2007.
25. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE: Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed Nanotechnol Biol Med, 2009, in press.
26. Dubertret B, Calame M, Libchaber AJ: Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat Biotechnol 19:365-370, 2001.
27. El-Sayed IH, Huang X, El-Sayed MA: Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated GNPs. Cancer Lett 239:129-135, 2006.
28. Faulk W, Taylor G: An immunocolloid method for the electron microscopy. Immunochemistry 8:1081-1083, 1979.
29. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990.
30. Fleming C, Forsyth A, Mackie R: Prevalence of gold contact hypersensitivity in the west of Scotland. Contact dermatitis 36:302-304, 1997.
31. Forestier J: Rheumatoid arthritis and its treatment by gold salts. J Lab Clin Med 20:827-40, 1935.
32. Fricker SP, Buckley RG: Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents. Anticancer Res 16:3755-3760, 1996.
33. Gannon CJ, Curley SA: The role of focal liver ablation in the treatment of unrespectable primary and secondary malignant liver tumours. Semin Radiat Oncol 15:265-272, 2005.
34. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA: Intracellular GNPs enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnol 6:2-10, 2008.
35. Ghosh PS, Kim Chae-Kyu, Han G, Forbes NS, Rotello VM: Efficient gene delivery vectors by tuning the surface charge density of aminoacid-functionalized GNPs. ACS Nano 2:2213-2218, 2008.
36. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA: Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Amer Chem Soc 131:2072-2073, 2009.
37. Glennås A, Kvien TK, Andrup O, Clarke-Jenssen O, Karstensen B, Brodin U: Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis. Br J Rheumatol 36:870-877, 1997.
38. Goodman CM, McCusker CD, Yilmaz T, Rotello VM: Toxicity of GNPs functionalized with cationic and anionic side chains. Bioconjugate Chem 15:897-900, 2004.
39. Haemmerich D, Laeseke PF: Thermal tumour ablation: Devices, clinical applications and future directions. Int J Hyperthermia 21:755-760, 2005.
40. Hirsch LR, Halas NJ, West JL: Whole-blood immunoassay facilitated by gold nanoshell-conjugate antibodies. Methods Mol Biol 303:101-111, 2005.
41. r clusters from various precursors. Rapid Commun Mass Spectrom 22:417-423, 2008.
42. Houška J, Panyala NR, Peña-Méndez EM, Havel J: Mass spectrometry of nanodiamonds. Rapid Commun Mass Spectrom 23:1125-1131, 2009a.
43. Houška J, Peña-Méndez EM, Kolář J, Frumar M, Wágner T, Havel J: Laser ablation of AgSbS2 and cluster analysis by time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 23:1715-1718, 2009b.
44. Huang SH: Gold nanoparticle-based immunochromatographic test for identification of Staphylococcus aureus from clinical specimens. Clin Chim Acta 373:139-143, 2006.
45. Jain KK: Nanotechnology-based drug delivery for cancer. Technol Cancer Res Treat 4:407-416, 2005.
46. Juzenas P, Chen W, Sun YP, Coelho MAN, Generalov R, Generalova N, Christensen IL: Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev 60:1600-1614, 2008.
47. Kam NW, Liu Z, Dai H: Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Edn Engl 45:577-581, 2006.
48. Kang H, DeLong R, Fisher MH, Juliano RL: Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res 22:2099-2106, 2005.
49. Krasovskii VI, Nagovitsyn IA, Chudinova GK, Savranskii VV, Karavanskii VA: Interaction of gold nanoparticles with bovine serum albumin. Bull Lebedev Phys Inst 34:321-324, 2007.
50. Kumar S, Harrison N, Richards-Kortum R, Sokolov K: Plasmonic nanosensors for imaging intracellular biomarkers in live cells. Nano Lett 7:1338-1343, 2007.
51. Landé K: Die gunstige, Heinflussing schleichender Dauerinfectionen surch Solganal. Munch Med Wchschr 74:1132-1139, 1927.
52. 2+) in Aqueous Media using DNA Functionalized GNPs. Angew Chem 46:4093-4096, 2007.
53. Lee SC, Parthasarathy R, Botwin K, Kunneman D, Rowold E, Lange G, Klover J, Abegg A, Zobel J, Beck T, Miller T, Hood W et al.: Biochemical and immunological properties of cytokines conjugated to dendritic polymers. Biomed microdevices 6:191-202, 2004.
54. Letfullin RR, Joenathan C, George TF, Zharov VP: Laser induced explosion of gold nanoparticles: potential role for nanophotothermolysis of cancer. Nanomedicine 1:473-480, 2006.
55. Lewinski N, Colvin V, Drezek R: Cytotoxicity of nanoparticles. Small 4:26-49, 2007.
56. Liao H, Nehl CL, Hafner JH: Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine 1:201-208, 2006.
57. Liu GL, Yin Y, Kunchakarra S, Mukherjee B, Gerion D, Jett SD, Bear DG, Gray JW, Alivisatos AP, Lee LP, Chen FF: A nanoplasmonic molecular ruler for measuring nuclease activity and DNA footprinting. Nat Nanotechnol 1:47-52, 2006.
58. Lu W, Xiong C, Zhang G, Huang Q, Zhang R, Zhang JZ, Li C: Targeted photo thermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res 15:876-886, 2009.
59. Mahdihassan S: Colloidal gold as an alchemical preparation. Janus 58:112-118, 1971.
60. Mahdihassan S: The tradition of alchemy in India. Am J Chin Med 9:23-33, 1981.
61. Mahdihassan S: Cinnabar-gold as the best alchemical drug of longevity, called Makaradhwaja in India. Am J Chin Med 13:93-108, 1985.
62. McKenna KE, Dolan O, Walsh MY, Burrows D: Contact allergy to gold sodium thiosulfate. Contact dermatitis 32:143-146, 1995.
63. Moghimi SM, Hunter AC, Murray JC: Nanomedicine: Current status and future prospects. FASEB J 19:311-330, 2005.
64. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S: Antiangiogenic properties of GNPs. Clin Cancer Res 11:3530-3534, 2005.
65. Mukherjee P, Bhattacharya R, Bone N, Lee YK, Patra CR, Wang S, Lu L, Charla S, Banerjee PC, Yaszemski MJ, Kay NE, Mukhopadhyay D: Potential therapeutic application of GNPs in B-chronic lymphocytic leukaemia (BCLL): enhancing apoptosis. J Nanobiotechnol 5:4, 2007.
66. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, Baxter SC: GNPs in biology: Beyond toxicity to cellular imaging. Acc Chem Res 41:1721-1730, 2008.
67. Nehl CL, Liao H, Hafner JH: Optical properties of star-shaped GNPs. Nano Lett 6:683-688, 2006.
68. Nehl CL, Hafner JH: Shape-dependent plasmon resonances of gold nanoparticles. J Mater Chem 18:2415-2419, 2008.
69. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y: PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343-347, 2006.
70. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L: Colloidal gold: a novel nanoparticle vector for tumour directed drug delivery. Drug Deliv 11:169-183, 2004.
71. Pan Y, Neuss S, Leifert, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W: Size-dependent cytotoxicity of GNPs. Small 3:1941-1949, 2007.
72. 4. J Nanosci Nanotechnol 7:1911-1915, 2007.
73. Panyala NR, Peña-Méndez EM, Havel J: Silver or silver nanoparticles: a hazardous threat to the environment and human health? J Appl Biomed 6:117-129, 2008.
74. Park SJ, Taton TA, Mirkin CA: Array-based electrical detection of DNA with nanoparticle probes. Science 295:1503-1509, 2002.
75. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasguptha AK: Cell selective response to GNPs. Nanomedicine: Nanotech Biol Med 3:111-119, 2007.
76. Peña-Méndez EM, Hernández-Fernaud JR, Nagender R, Houška J, Havel: The chemistry of gold clusters in plasma generated with MALDI, Laser desorption ionization and laser ablation from various precursors. Chem Listy 102:s1394-s1398, 2008.
77. Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A, Sokolov J, Ulman A, Rafailovich M: Adverse effects of citrate/GNPs on human dermal fibroblasts. Small 2:766-773, 2006.
78. Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA: Significant long-term survival after radiofrequency ablation of unrespectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12:616-628, 2005.
79. Räsänen L, Kaipianen-Seppänen O, Myllykangas-Luosujärvi R, Käsnänen T, Pollari P, Saloranta P, Horsmanheimo M: Hypersensitivity to gold sodium thiomalate-induced dermatosis. Br J Dermatol 141:683-688, 1999.
80. Rayavarapu RG, Petersen W, Ungureanu C, Post JN, Leeuwen TGV, Manohar S: Synthesis and bioconjugation of GNPs as potential molecular probes for light-based imaging techniques. Int J Biomed Imaging 2007:29817-29827, 2007.
81. Roth J, Bendayan M, Carlemalm E, Villiger W, Garavito M: Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J Histochem Cytochem 29:663-671, 1981.
82. Salata O: Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3, 2004.
83. Sannella AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF, Majori G, Severini C: New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications. FEBS Lett 582:844-847, 2008.
84. Shaw IC: Gold-based therapeutic agents. Chem Rev 99:2589-2600, 1999.
85. Svensson A, Möller H, Björkner B, Bruze M, Leden I, Theander J, Ohlsson K, Linder C: Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines. BMC Dermatol 2:2-6, 2002.
86. Tan WB, Zhang Y: Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications. J Biomed Mater Res A 75:56-62, 2005.
87. Traber KE, Okamoto H, Kurono C, Baba M, Saliou C, Soji T, Packer L, Okamoto T: Anti-rheumatic compound aurothioglucose inhibits tumour necrosis factor-a-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int Immunol 11:143-150, 1998.
88. Triulzi RC, Micic M, Orbulescu J, Giordani S, Mueller B, Leblanc RM: Antibody-gold quantum dot-PAMAM dendrimer complex as an immunoglobin immunoassay. Analyst 133:667-672, 2008.
89. Tsvetkov DE, Cheshev PE, Tuzikov AB, Chinarev AA, Pazynina GV, Sablina MA, Gambaryan AS, Bovin NV, Rieben R, Shashkov AS, Nifant'ev NE: Neoglycoconjugates based on dendrimer poly(aminoamides). Russ J Bioorg Chem 28:470-486, 2002.
90. Vamnes JS, Morken T, Helland S, Gjerdet NR: Dental gold alloys and contact hypersensitivity. Contact Dermatitis 42:128-133, 2000.
91. Wang W, Chen Q, Jiang C, Yang D, Liu X, Xu S. One-step synthesis of biocompatible gold nanoparticles using gallic acid in the presence of poly-(N-vinyl-2-pyrrolidone). Colloid Surface A 301:73-79, 2007.
92. Wang X, Inapagolla R, Kannan S, Lieh-Lai M, Kannan RM: Synthesis, characterization, and in vitro activity of dendrimer-streptokinase conjugates. Bioconjugate Chem 18:791-799, 2007.
93. Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K: Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano 3:80-86, 2009.
94. Wiwanitkit V, Sereemaspun A, Rojanathanes R: Effect of gold nanoparticles on spermatozoa: the first world report. Fertil Steril 91:e7-e8, 2009.
95. Wright IH, Vesey CJ: Acute poisoning with gold cyanide. Anaesthesia 41:936-939, 1986.
96. Wu ML Tsai WJ, Ger J, Deng JF, Tsay SH, Yang MH: Cholestatic hepatitis caused by acute gold potassium cyanide poisoning. Clin Toxicol 39:739-743, 2001.
97. Zhang Z, Yang X, Zhang Y, Zeng B, Wang S, Zhu T, Roden RB, Chen Y, Yang R: Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single walled carbon nanotubes suppresses tumour growth. Clin Cancer Res 12:4933-4939, 2006.
98. Zhang J, Atay T, Nurmikko AV: Optical detection of brain cell activity using plasmonic GNPs. Nano Lett 9:519-524, 2009.
99. Zharov VP, Mercer KE, Galitovskaya EN, Smeltzer MS: Photo thermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with GNPs. Biophys J 90:619-627, 2006.